
Non-Alcoholic Steatohepatitis (NASH) Global Market Report 2025
Description
Non-Alcoholic Steatohepatitis (NASH) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on non-alcoholic steatohepatitis (nash) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for non-alcoholic steatohepatitis (nash) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The non-alcoholic steatohepatitis (nash) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Type: Solid; Liquid
2) By Product: Vitamin E and Pioglitazone; Ocaliva; Elafibranor; Selonsertib and Cenicriviroc; Other Products
3) By Disease Cause: Hypertension; Heart Disease; High Blood Lipid; Type 2 Diabetes; Obesity
4) By Sales Channel: Hospital Pharmacy; Retail Pharmacy; Online Provider
5) By Application: Oral; Parenteral
Subsegments:
1) By Solid: Tablets; Capsules; Other Solid Dosage Forms
2) By Liquid: Oral Solutions; Syrups; Injectable Solutions; Other Liquid Dosage Forms
Companies Mentioned: NGM Biopharmaceuticals Inc.; Novartis AG; AstraZeneca plc.; GlaxoSmithKline plc.; F. Hoffmann-La Roche AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
This report focuses on non-alcoholic steatohepatitis (nash) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for non-alcoholic steatohepatitis (nash) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The non-alcoholic steatohepatitis (nash) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Type: Solid; Liquid
2) By Product: Vitamin E and Pioglitazone; Ocaliva; Elafibranor; Selonsertib and Cenicriviroc; Other Products
3) By Disease Cause: Hypertension; Heart Disease; High Blood Lipid; Type 2 Diabetes; Obesity
4) By Sales Channel: Hospital Pharmacy; Retail Pharmacy; Online Provider
5) By Application: Oral; Parenteral
Subsegments:
1) By Solid: Tablets; Capsules; Other Solid Dosage Forms
2) By Liquid: Oral Solutions; Syrups; Injectable Solutions; Other Liquid Dosage Forms
Companies Mentioned: NGM Biopharmaceuticals Inc.; Novartis AG; AstraZeneca plc.; GlaxoSmithKline plc.; F. Hoffmann-La Roche AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
175 Pages
- 1. Executive Summary
- 2. Non-Alcoholic Steatohepatitis (NASH) Market Characteristics
- 3. Non-Alcoholic Steatohepatitis (NASH) Market Trends And Strategies
- 4. Non-Alcoholic Steatohepatitis (NASH) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
- 5. Global Non-Alcoholic Steatohepatitis (NASH) Growth Analysis And Strategic Analysis Framework
- 5.1. Global Non-Alcoholic Steatohepatitis (NASH) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Non-Alcoholic Steatohepatitis (NASH) Market Growth Rate Analysis
- 5.4. Global Non-Alcoholic Steatohepatitis (NASH) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Non-Alcoholic Steatohepatitis (NASH) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Non-Alcoholic Steatohepatitis (NASH) Total Addressable Market (TAM)
- 6. Non-Alcoholic Steatohepatitis (NASH) Market Segmentation
- 6.1. Global Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Solid
- Liquid
- 6.2. Global Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Vitamin E and Pioglitazone
- Ocaliva
- Elafibranor
- Selonsertib and Cenicriviroc
- Other Products
- 6.3. Global Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Disease Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hypertension
- Heart Disease
- High Blood Lipid
- Type 2 Diabetes
- Obesity
- 6.4. Global Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacy
- Retail Pharmacy
- Online Provider
- 6.5. Global Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Parenteral
- 6.6. Global Non-Alcoholic Steatohepatitis (NASH) Market, Sub-Segmentation Of Solid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Tablets
- Capsules
- Other Solid Dosage Forms
- 6.7. Global Non-Alcoholic Steatohepatitis (NASH) Market, Sub-Segmentation Of Liquid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral Solutions
- Syrups
- Injectable Solutions
- Other Liquid Dosage Forms
- 7. Non-Alcoholic Steatohepatitis (NASH) Market Regional And Country Analysis
- 7.1. Global Non-Alcoholic Steatohepatitis (NASH) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Non-Alcoholic Steatohepatitis (NASH) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Market
- 8.1. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Disease Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Non-Alcoholic Steatohepatitis (NASH) Market
- 9.1. China Non-Alcoholic Steatohepatitis (NASH) Market Overview
- 9.2. China Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Disease Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Non-Alcoholic Steatohepatitis (NASH) Market
- 10.1. India Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Disease Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Non-Alcoholic Steatohepatitis (NASH) Market
- 11.1. Japan Non-Alcoholic Steatohepatitis (NASH) Market Overview
- 11.2. Japan Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Disease Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Non-Alcoholic Steatohepatitis (NASH) Market
- 12.1. Australia Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Disease Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Non-Alcoholic Steatohepatitis (NASH) Market
- 13.1. Indonesia Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Disease Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Non-Alcoholic Steatohepatitis (NASH) Market
- 14.1. South Korea Non-Alcoholic Steatohepatitis (NASH) Market Overview
- 14.2. South Korea Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Disease Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Non-Alcoholic Steatohepatitis (NASH) Market
- 15.1. Western Europe Non-Alcoholic Steatohepatitis (NASH) Market Overview
- 15.2. Western Europe Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Disease Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Non-Alcoholic Steatohepatitis (NASH) Market
- 16.1. UK Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Disease Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Non-Alcoholic Steatohepatitis (NASH) Market
- 17.1. Germany Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Disease Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Non-Alcoholic Steatohepatitis (NASH) Market
- 18.1. France Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Disease Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Non-Alcoholic Steatohepatitis (NASH) Market
- 19.1. Italy Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Disease Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Non-Alcoholic Steatohepatitis (NASH) Market
- 20.1. Spain Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Disease Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Non-Alcoholic Steatohepatitis (NASH) Market
- 21.1. Eastern Europe Non-Alcoholic Steatohepatitis (NASH) Market Overview
- 21.2. Eastern Europe Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Disease Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Non-Alcoholic Steatohepatitis (NASH) Market
- 22.1. Russia Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Disease Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Non-Alcoholic Steatohepatitis (NASH) Market
- 23.1. North America Non-Alcoholic Steatohepatitis (NASH) Market Overview
- 23.2. North America Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Disease Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Non-Alcoholic Steatohepatitis (NASH) Market
- 24.1. USA Non-Alcoholic Steatohepatitis (NASH) Market Overview
- 24.2. USA Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Disease Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Non-Alcoholic Steatohepatitis (NASH) Market
- 25.1. Canada Non-Alcoholic Steatohepatitis (NASH) Market Overview
- 25.2. Canada Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Disease Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Non-Alcoholic Steatohepatitis (NASH) Market
- 26.1. South America Non-Alcoholic Steatohepatitis (NASH) Market Overview
- 26.2. South America Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Disease Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Non-Alcoholic Steatohepatitis (NASH) Market
- 27.1. Brazil Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Disease Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Non-Alcoholic Steatohepatitis (NASH) Market
- 28.1. Middle East Non-Alcoholic Steatohepatitis (NASH) Market Overview
- 28.2. Middle East Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Disease Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Non-Alcoholic Steatohepatitis (NASH) Market
- 29.1. Africa Non-Alcoholic Steatohepatitis (NASH) Market Overview
- 29.2. Africa Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Disease Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Non-Alcoholic Steatohepatitis (NASH) Market Competitive Landscape And Company Profiles
- 30.1. Non-Alcoholic Steatohepatitis (NASH) Market Competitive Landscape
- 30.2. Non-Alcoholic Steatohepatitis (NASH) Market Company Profiles
- 30.2.1. NGM Biopharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. GlaxoSmithKline plc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 31. Non-Alcoholic Steatohepatitis (NASH) Market Other Major And Innovative Companies
- 31.1. The Takeda Pharmaceutical Company Limited
- 31.2. Gilead Sciences Inc.
- 31.3. Novo Nordisk A/S
- 31.4. Genfit SA
- 31.5. Cadila Pharmaceuticals Ltd.
- 31.6. Intercept Pharmaceuticals Inc.
- 31.7. Enanta Pharmaceuticals Inc.
- 31.8. Blade Therapeutics Inc.
- 31.9. Galmed Pharmaceuticals Inc.
- 31.10. Immuron Limited
- 31.11. Terns Pharmaceuticals Inc.
- 31.12. Tobira Therapeutics Inc.
- 31.13. Arena Pharmaceuticals Inc.
- 31.14. Galectin Therapeutics Inc.
- 31.15. Viking Therapeutics
- 32. Global Non-Alcoholic Steatohepatitis (NASH) Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Non-Alcoholic Steatohepatitis (NASH) Market
- 34. Recent Developments In The Non-Alcoholic Steatohepatitis (NASH) Market
- 35. Non-Alcoholic Steatohepatitis (NASH) Market High Potential Countries, Segments and Strategies
- 35.1 Non-Alcoholic Steatohepatitis (NASH) Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Non-Alcoholic Steatohepatitis (NASH) Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Non-Alcoholic Steatohepatitis (NASH) Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.